Development of vaccines against bovine tuberculosis (Q36492602)

14 August 2017

1 reference

title

Development of vaccines against bovine tuberculosis (English)

1 reference

14 August 2017

0 references

Hogarth PJ

1

1 reference

14 August 2017

Hewinson RG

series ordinal

2

1 reference

14 August 2017

Vordermeier HM

series ordinal

3

1 reference

14 August 2017

publication date

1 June 2006

1 reference

Journal of Pharmacy and Pharmacology

14 August 2017

published in

1 reference

14 August 2017

volume

58

1 reference

14 August 2017

issue

6

1 reference

14 August 2017

page(s)

749-757

1 reference

Genomic approach to identification of Mycobacterium bovis diagnostic antigens in cattle

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Vaccination of mice and cattle with plasmid DNA encoding the Mycobacterium bovis antigen MPB83.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Prime-boost strategies for malaria vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

The complete genome sequence of Mycobacterium bovis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Evaluation of adjuvants for protein vaccines against tuberculosis in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c--a member of the esat-6 gene family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

The role of CpG in DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Recent progress in the development and testing of vaccines against human tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Prime-boost immunisation strategies for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Progress in DNA-based heterologous prime-boost immunization strategies for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

The ESAT-6/WXG100 superfamily -- and a new Gram-positive secretion system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Prospects for a better vaccine against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCG

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Tuberculosis vaccines: the past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Effect of different adjuvants on the immune responses of cattle vaccinated with Mycobacterium tuberculosis culture filtrate proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Mycobacterium bovis infection and control in domestic livestock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Protective efficacy induced by Mycobacterium bovis bacille Calmette-Guèrin can be augmented in an antigen independent manner by use of non-coding plasmid DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Vaccination of animals against Mycobacterium bovis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

Vaccination with DNA vaccines encoding MPB70 or MPB83 or a MPB70 DNA prime-protein boost does not protect cattle against bovine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.58.6.0005

21 January 2018

Identifiers

DOI

10.1211/JPP.58.6.0005

1 reference

release_ououuatppbav5f6najyijcucvy

14 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ououuatppbav5f6najyijcucvy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference